CSHL researchers discover three new genes that cause lung cancerOctober 09, 2007Reversing the effects of these three genes can block tumor formation Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered three genes that interact with cancerous results in 20% of lung cancers. The three genes are located next to each other on human chromosome 14 and two are known to play key roles in fetal lung development. According to CSHL lead investigator David Mu, "lung cancer cells in adults can reactivate genes that are normally active in the earliest stages of lung development. We identified the mutation that triggers this abnormal re-activation of developmental genes and showed that if you turn off these genes, you stop the cancer." The CSHL research found that the three genes termed TTF1, NKX2-8, and PAX9 interact to reactivate what appears to be an early fetal gene expression pattern that results in cancer tumor growth. "The collaboration of these genes and the fact that they are so close together on the chromosome may explain why this mutation is so common in lung cancer," said CSHL investigator and co-author Scott Powers. In collaboration with Dr. William Gerald at the Memorial Sloan Kettering Cancer Center, the study finds that the mutation is more prevalent in late stage lung cancer and is possibly a risk factor for recurrence.
The CSHL-led research demonstrates that the cancerous results of the mutation can be reversed. In the future, this may lead to new treatment options for patients. Cancer research that looks at one gene at a time ignores the fact that cancers are usually caused by multiple collaborating cancer genes. Mutations in these genes determine the clinical outcome of the cancerous growth and how the cancer responds to treatment. "At CSHL we are excited about the ability to apply direct genomic analysis to human cancers and discover more about how cancer genes interact," said Howard Hughes Medical Institute Investigator and CSHL Cancer Center Deputy Director Scott Lowe. Cold Spring Harbor Laboratory | |||||||||||||||||||||
|
Related Lung Cancer Current Events and Lung Cancer News Articles MU study reveals effective anti-tobacco ads should either scare or disgust viewers Now's the perfect time to increase anti-smoking campaigns - Nov. 20 is the American Cancer Society's Great American Smokeout. Iressa proves just as effective as chemotherapy for lung cancer Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M. D. Anderson Cancer Center. Novel 4-drug combination proves safe for lung cancer treatment The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center. The miseries of allergies just may help prevent some cancers, study finds There may be a silver -- and healthy -- lining to the miserable cloud of allergy symptoms: Sneezing, coughing, tearing and itching just may help prevent cancer -- particularly colon, skin, bladder, mouth, throat, uterus and cervix, lung and gastrointestinal tract cancer, according to a new Cornell study. Researchers aim to over-stress already taxed mantle cell lymphoma cells Cancer cells are already stressed by the fast pace they require to grow and spread and scientists believe a little more stress just may kill them. Researchers describe how chronic inflammation can lead to stomach cancer A multi-center research team, led by Columbia University Medical Center, has uncovered a major contributor to the cause of stomach cancer - the second leading cause of cancer-related mortality in the world. Media coverage of lung cancer is increasing, and increasingly negative, new report shows CancerCare today announced that despite an overall increase in news reporting on lung cancer, the overall tone of lung cancer media coverage has become significantly more negative. Major Source of Radon Exposure Overlooked at Former Ohio Uranium Processing Plant University of Cincinnati (UC) scientists say that a recent scientific study of a now-closed uranium processing plant near Cincinnati has identified a second, potentially more significant source of radon exposure for former workers. Study finds that practice makes perfect in lung cancer surgery Patients operated on by surgeons who do not routinely remove cancer from the lungs may be at a higher risk for complications, according to a study conducted by researchers at Duke University Medical Center. Red wine may lower lung cancer risk Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a report in the October issue of Cancer Epidemiology, Biomarkers & Prevention¸ a journal of the American Association for Cancer Research. More Lung Cancer Current Events and Lung Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||